AI-generated summary, not yet reviewed by Better Utah staff. Please consult the bill text.

Utah law currently requires health care providers offering stem cell therapy that isn't FDA-approved to give patients written notice, display that notice in their office, include it in advertising, and get signed informed consent before treatment. This bill adds a new requirement for suppliers: before a person can provide human cells, tissues, or cellular/tissue-based products (such as placental material) to a health care provider for use in stem cell therapy, that provider must first give the supplier written confirmation that they will properly notify their patients as already required under the existing law. The bill does not change the patient notice, consent form, or advertising requirements themselves — it simply adds a paperwork check between suppliers and providers to help ensure patient notification actually happens.